These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
8. Risk factors for rate of decline in forced expiratory volume in one second in children and adolescents with cystic fibrosis. Konstan MW; Morgan WJ; Butler SM; Pasta DJ; Craib ML; Silva SJ; Stokes DC; Wohl ME; Wagener JS; Regelmann WE; Johnson CA; J Pediatr; 2007 Aug; 151(2):134-9, 139.e1. PubMed ID: 17643762 [TBL] [Abstract][Full Text] [Related]
9. Lung clearance index predicts pulmonary exacerbations in young patients with cystic fibrosis. Vermeulen F; Proesmans M; Boon M; Havermans T; De Boeck K Thorax; 2014 Jan; 69(1):39-45. PubMed ID: 24021874 [TBL] [Abstract][Full Text] [Related]
10. Blood mRNA biomarkers for detection of treatment response in acute pulmonary exacerbations of cystic fibrosis. Nick JA; Sanders LA; Ickes B; Briones NJ; Caceres SM; Malcolm KC; Brayshaw SJ; Chacon CS; Barboa CM; Jones MC; St Clair C; Taylor-Cousar JL; Nichols DP; Sagel SD; Strand M; Saavedra MT Thorax; 2013 Oct; 68(10):929-37. PubMed ID: 23783371 [TBL] [Abstract][Full Text] [Related]
11. Objective measurement of cough during pulmonary exacerbations in adults with cystic fibrosis. Smith JA; Owen EC; Jones AM; Dodd ME; Webb AK; Woodcock A Thorax; 2006 May; 61(5):425-9. PubMed ID: 16449266 [TBL] [Abstract][Full Text] [Related]
12. Desaturation during the 3-minute step test predicts impaired 12-month outcomes in adult patients with cystic fibrosis. Holland AE; Rasekaba T; Wilson JW; Button BM Respir Care; 2011 Aug; 56(8):1137-42. PubMed ID: 21496365 [TBL] [Abstract][Full Text] [Related]
14. A semiparametric approach to estimate rapid lung function decline in cystic fibrosis. Szczesniak RD; McPhail GL; Duan LL; Macaluso M; Amin RS; Clancy JP Ann Epidemiol; 2013 Dec; 23(12):771-7. PubMed ID: 24103586 [TBL] [Abstract][Full Text] [Related]
15. Exacerbation frequency and clinical outcomes in adult patients with cystic fibrosis. de Boer K; Vandemheen KL; Tullis E; Doucette S; Fergusson D; Freitag A; Paterson N; Jackson M; Lougheed MD; Kumar V; Aaron SD Thorax; 2011 Aug; 66(8):680-5. PubMed ID: 21680566 [TBL] [Abstract][Full Text] [Related]
16. Longitudinal study of oxidative status in 312 cystic fibrosis patients in stable state and during bronchial exacerbation. Lagrange-Puget M; Durieu I; Ecochard R; Abbas-Chorfa F; Drai J; Steghens JP; Pacheco Y; Vital-Durand D; Bellon G Pediatr Pulmonol; 2004 Jul; 38(1):43-9. PubMed ID: 15170872 [TBL] [Abstract][Full Text] [Related]
17. Association of respiratory viral infections with pulmonary deterioration in patients with cystic fibrosis. Wang EE; Prober CG; Manson B; Corey M; Levison H N Engl J Med; 1984 Dec; 311(26):1653-8. PubMed ID: 6504106 [TBL] [Abstract][Full Text] [Related]
18. Plasma calprotectin predicts mortality in patients with ST segment elevation myocardial infarction treated with primary percutaneous coronary intervention. Jensen LJ; Pedersen S; Bjerre M; Mogelvang R; Jensen JS; Flyvbjerg A J Interv Cardiol; 2010 Apr; 23(2):123-9. PubMed ID: 20337863 [TBL] [Abstract][Full Text] [Related]